NAD+ and cellular aging: what do we actually know?

Ilustracija molekularne strukture povezane s NAD+ metabolizmom

Author: Vivacel360 Team

NAD+ participates in energy production, DNA repair, and cellular signaling. That is precisely why it has become one of the most interesting molecules in aging research—but the science is more complex than the simple idea that “more NAD+ means slower aging.”

In recent years, NAD+ has become almost synonymous with longevity.

There is talk of energy, mitochondria, sirtuins, DNA repair, and “rejuvenating cells.” Behind some of these claims lies truly fascinating biology.

But there is a major scientific difference between the question “Is NAD+ important to the cell?” and “Can we slow human aging by increasing NAD+?”

The answer to the first question is very clear.

The answer to the second is not yet.

What exactly is NAD+?

NAD+ is an abbreviation for nicotinamide adenine dinucleotide.

It is found in virtually all living cells and belongs to the class of molecules without which normal cellular metabolism could not function.

One of its fundamental functions is electron transfer.

NAD+ can accept electrons and become its reduced form:

NAD+ ⇄ NADH

This seemingly simple exchange enables a large number of reactions in which the cell converts energy from nutrients into a form it can use.

Therefore, NAD+ is not a classic “energy ingredient.”

It is part of the chemical system by which the cell produces energy.

NAD+ and energy production

When we consume carbohydrates, fats, or proteins, the energy from them does not pass directly into our muscles or brain.

Nutrients first undergo a series of metabolic reactions.

During processes such as glycolysis, the citric acid cycle, and fatty acid oxidation, NAD+ accepts electrons and becomes NADH.

NADH then carries them to the mitochondrial electron transport chain.

There, their energy helps create a proton gradient that drives ATP synthase, the enzyme responsible for producing ATP.

ATP is the cell’s basic energy currency.

In other words:

nutrients → NADH → mitochondria → ATP

Without a constant cycle between NAD+ and NADH, this system could not function normally.

But NAD+ is not important only for energy

This is where the story becomes particularly interesting.

NAD+ is not just a molecule that carries electrons.

Certain enzymes consume it as a substrate so they can perform their functions.

Among the most important are:

sirtuins

PARP enzymes

CD38

and other enzyme systems involved in cellular signaling, stress response, and metabolism.

Because of this, the amount and availability of NAD+ link several processes that are currently at the very center of aging biology.

Sirtuins: why are they mentioned so often in longevity?

Sirtuins are a family of enzymes designated SIRT1 to SIRT7.

They need NAD+ to work.

They participate in regulating proteins involved in metabolism, mitochondrial function, cellular stress response, gene expression, and the maintenance of cellular homeostasis.

It is precisely because of the connection between NAD+, sirtuins, and the aging process that a very attractive idea has emerged:

more NAD+ → more sirtuin activity → healthier aging

Biology, however, is not that linear.

Sirtuin activity depends on many more factors than the concentration of NAD+ alone, and different sirtuins act in different parts of the cell and have different functions.

Therefore, the fact that sirtuins use NAD+ cannot automatically lead to the conclusion that simply increasing NAD+ in a healthy person must result in an “anti-aging” effect.

NAD+ and DNA repair

Our DNA is not a static structure.

Every day it is exposed to a large number of chemical and physical influences that can cause damage.

Cells therefore possess a series of sophisticated systems for detecting and repairing it.

One important group of enzymes in this process is the PARP enzymes, especially PARP1.

When they recognize certain types of DNA damage, they use NAD+ as a substrate to create poly(ADP-ribose) chains, which helps organize the cell’s response to damage.

This means that increased activation of certain PARP enzymes can simultaneously increase NAD+ consumption.

This gives rise to one of the more interesting hypotheses about aging.

If the amount of cellular damage and inflammatory burden increases with age, the increased activity of enzymes that use NAD+ could contribute to changes in its cellular status.

But that is not the only mechanism.

CD38: another major NAD+ consumer

CD38 is an enzyme present in various cells and is particularly interesting because of its connection to the immune system and inflammation.

It also breaks down NAD+.

Clinical research suggests that changes in CD38 activity associated with aging and chronic inflammation may be one of the reasons for reduced NAD+ availability in certain tissues.

Therefore, NAD+ is not viewed in isolation today.

The question is not just:

“How much do we produce?”

but also:

“How much do we consume?”

Does NAD+ really decline with age?

This is one of the most frequently repeated claims in the longevity industry:

“NAD+ declines drastically with age.”

There is data supporting age-related changes in NAD+ metabolism.

In some human tissues, lower concentrations of NAD+ have been recorded in older individuals. One study of human skin, for example, found a negative correlation between NAD+ levels and age.

But a contemporary review of human research published in Nature Metabolism in 2025 highlights an important point:

evidence of a universal decline in NAD+ across all human tissues is still limited.

Results depend on the tissue, the method of measurement, health status, and other factors. The amount of data from human tissues is still relatively small compared to the vast amount of data from animal models.

Therefore, it is more accurate to say:

aging is associated with changes in NAD+ metabolism and reduced NAD+ in some tissues, but it is not scientifically justified to assume an equal decline in every cell and in every person.

Why would NAD+ decrease at all?

There are several possible reasons.

One is reduced biosynthesis.

Another is increased consumption.

A third is altered metabolism associated with chronic inflammation, oxidative stress, DNA damage, and mitochondrial dysfunction.

PARP enzymes, CD38, and sirtuins all use the same cellular NAD+ pool for different functions.

Because of this, we can think of NAD+ as a metabolic resource that is simultaneously used by several systems.

But even that analogy is simplified.

The cell does not have just one NAD+ pool

One of the more important discoveries in modern NAD+ biology is that the cell does not simply have one large common pool of this molecule.

There are different NAD+ pools in:

the cytosol

the nucleus

the mitochondria

and other cellular compartments.

Their concentrations, regulation, and interconnection may differ.

This further complicates the question of supplementation.

Even if an intervention increases the concentration of NAD-related metabolites in the blood, that does not automatically mean it has equally increased NAD+ in the mitochondria of muscles, neurons, or some other target tissue.

Increasing the number in the blood and changing the biology of a specific cell are not necessarily the same thing.

How does the body create NAD+?

The body can create NAD+ through several metabolic pathways.

It uses compounds related to vitamin B3 as precursors, including:

nicotinamide (NAM)

nicotinic acid (NA)

nicotinamide riboside (NR)

and nicotinamide mononucleotide (NMN) also enters NAD+ metabolism.

The so-called salvage pathway is particularly important, by which cells recycle nicotinamide and recreate NAD+.

This shows how efficient the system is.

The cell constantly uses, breaks down, and recreates NAD+.

Can we simply increase NAD+?

This is the question that has launched the entire field of NAD+ supplementation.

In animal models, the results are very interesting.

Increasing NAD+ through precursors such as NR or NMN in various experimental models has been associated with improvements in certain metabolic, mitochondrial, and functional parameters.

In some models, effects associated with healthy aging have also been recorded.

This is one of the main reasons why the field has become so popular.

But then comes the most important question:

What happens in humans?

The picture here is considerably less spectacular.

What do human studies show?

Clinical research has shown that oral precursors such as NR and NMN can increase certain NAD+-related metabolites in the blood or in specific cells.

So, there is a clear biochemical effect.

But:

increasing biomarkers is not the same as proving life extension or a slowing of aging.

The latest systematic review of preclinical and clinical evidence concludes that NR and NMN show biological activity in humans and have generally been well tolerated during shorter studies, but the results for functional, metabolic, and other health outcomes remain heterogeneous and often without a significant effect.

The review published in Nature Metabolism in 2025 also concludes that the clinical effects of NAD+ precursors on healthy aging to date are limited and that higher-quality, longer studies are needed.

And what about “life extension”?

For now, we have no high-quality evidence that NAD+ supplementation extends human life.

This is a particularly important difference.

An experiment in mice can show changes in metabolism, function, or even lifespan.

But humans live for decades, have completely different physiology, diets, environments, and health factors.

Therefore, results from laboratory and animal models cannot simply be translated into the claim:

“NAD+ slows human aging.”

Current human evidence does not support this.

NAD+ and NAD+ precursors are not the same

This is another important difference that is often lost in marketing.

Most modern clinical research on increasing NAD+ does not necessarily use the NAD+ molecule itself.

Its precursors are often studied, especially:

NR

and

NMN

The body then metabolizes these molecules through its own pathways.

Therefore, the results of a study on one precursor cannot automatically be attributed to every product that says “NAD+.”

The same applies to oral NAD+, intravenous NAD+, NR, and NMN.

These are different interventions with different pharmacology.

Currently, there is a particular lack of high-quality clinical outcomes for the direct intravenous or oral administration of NAD+ itself in the context of “anti-aging.” The latest systematic review did not find appropriate controlled studies of intravenous or intramuscular NAD+ that would prove an anti-aging or wellness effect.

Why is NAD+ so interesting then?

Because it is precisely at the intersection of several processes associated with aging.

Energy.

NAD+/NADH enables the electron transfer required for metabolism and ATP production.

DNA.

PARP enzymes use NAD+ in the response to certain types of DNA damage.

Cellular regulation.

Sirtuins use NAD+ and participate in the regulation of metabolism and the stress response.

Mitochondria.

Changes in NAD+ metabolism can affect mitochondrial function.

Inflammation.

Enzymes such as CD38 link NAD+ metabolism to immune and inflammatory processes.

Therefore, NAD+ is not interesting because some simple “molecular switch for youth” has been discovered.

It is interesting precisely because it links so many fundamental cellular systems.

Aging is not the deficiency of a single molecule

Perhaps the biggest mistake in longevity marketing is the idea that we can reduce an extremely complex process to a single value.

Aging involves changes in the genome, epigenetics, mitochondria, proteins, the immune system, metabolism, stem cells, and intercellular communication.

NAD+ overlaps with many of these systems.

But that does not mean that aging is simply a “NAD+ deficiency.”

Today’s literature reviews warn precisely because we still do not fully understand how NAD+ metabolism differs among tissues, how it changes during normal human aging, and which people—if any—could benefit most from its pharmacological increase.

Between biology and the longevity hype

We can say two things about NAD+ at the same time.

First:

NAD+ is one of the fundamental molecules of human metabolism and an extremely interesting area of aging biology research.

Second:

we still have no evidence that simply increasing NAD+ in humans means slower aging or a longer life.

These two sentences are not a contradiction.

They are precisely what science currently shows.

And perhaps that is the best way to view NAD+.

Not as a “molecule of youth.”

But as one of the molecules through which we can better understand how the cell links energy, repair, stress, and time.

Related product: Vivacel360 NAD+ – a dietary supplement in a liposomal formula.

Literature and sources

[1] Lautrup S, Hou Y, Fang EF, Bohr VA. Roles of NAD+ in Health and Aging. Cold Spring Harbor Perspectives in Medicine. 2024;14(1):a041193. Review of the role of NAD+ in metabolism, energy, DNA repair, mitophagy, and aging.

[2] Migaud ME, Ziegler M, Baur JA. Regulation of and challenges in targeting NAD+ metabolism. Nature Reviews Molecular Cell Biology. 2024;25:822–840. Review of NAD+ metabolism, cellular NAD+ pools, and the limitations and open questions associated with NAD+ supplementation.

[3] NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nature Metabolism.2025;7:1974–1990. Critical review of human evidence on changes in NAD+ during aging and the results of precursor supplementation. Source

[4] Covarrubias AJ et al. / review of the clinical pharmacology of NAD+. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocrine Reviews. Review of preclinical and early clinical data and the limitations of their translation to humans.

[5] Massudi H et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLOS ONE.2012. A study of human tissue that found a connection between age, DNA damage, PARP activity, and lower levels of NAD+.

[6] NAD metabolism: Role in senescence regulation and aging. Review of the relationship between NAD+, cellular senescence, and aging, and the limitations of existing clinical research on NR and NMN.

[7] The therapeutic perspective of NAD+ precursors in age-related diseases. Biochemical and Biophysical Research Communications. 2024;702:149590. Review of the potential role of NAD+ precursors and the fact that their clinical effects are still under investigation.

[8] NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. 2026. The systematic review concludes that NR and NMN can increase NAD-related biomarkers, but that clinical efficacy for anti-aging and wellness outcomes remains unproven.

[9] The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Review of human research on NMN and the differences between increasing NAD+ in the blood and the effect in individual tissues.

[10] Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing. Review of NR, NMN, and other NAD+ precursors and the difference between results obtained in animal models and in humans.

The content of this article is for informational purposes and does not replace the advice of a doctor or pharmacist. Dietary supplements are not a substitute for a balanced and varied diet and a healthy lifestyle.